{"id":"W4407684810","doi":"10.1016/j.jhep.2025.01.040","title":"A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Cisplatin; Gemcitabine; Biliary tract cancer; Medicine; Oncology; Internal medicine; Biliary tract; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002719936,0.001712017,0.004424852,0.0005370531,0.0006029219,0.001418296,0.001589552,0.001632766,0.005985894],"category_scores_gemma":[0.002279246,0.0009081197,0.002975047,0.0007402379,0.001546971,0.001423626,0.000579014,0.005019568,0.0008652424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001914946,"about_ca_system_score_gemma":0.002446842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002483689,"about_ca_topic_score_gemma":0.005765848,"domain_scores_codex":[0.9987646,0.0007873644,0.00006089508,0.0001653731,0.00007424155,0.0001475625],"domain_scores_gemma":[0.9978045,0.0006435136,0.0004180773,0.0002175136,0.0001245658,0.0007918558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9834579,0.006108333,0.0003967661,0.0002443801,0.0007646503,0.00001644429,0.00002493414,0.0002674554,0.001247002,0.00005144452,0.0002940532,0.007126635],"study_design_scores_gemma":[0.9142194,0.08257586,0.001364963,0.0000243583,0.0007131958,0.0000297466,0.00002442212,0.0002924706,0.0003122104,0.00007035265,0.0003605896,0.00001236836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895862,0.004244321,0.0004339735,0.0005373348,0.0004166754,0.002491447,0.0007675411,0.00007164843,0.001450869],"genre_scores_gemma":[0.9876763,0.003265779,0.001754371,0.000983099,0.0004278469,0.002394366,0.001243802,0.00004052042,0.002214029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005985894,"threshold_uncertainty_score":0.02002478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01892789173198145,"score_gpt":0.3478852274323013,"score_spread":0.3289573357003199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}